Your browser doesn't support javascript.
loading
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
Cui, Zhaoqiang; Qiu, Zhaohui; Cheng, Wenli; Hu, Wei; Ma, Genshan; Cai, Xiaojun; Jin, Yafei; Zhao, Yi; He, Liqun; Li, Ying; Bu, Peili; Chen, Xiaoping; Wang, Ruxing; Chen, Lin; Dong, Peng; Feng, Liuliu; Han, Xuebin; Hong, Mei; Hou, Yinglong; Liao, Minlei; Wang, Mingliang; Wang, Xiaoyan; Xie, Jianhong; Xu, Yawei; Wang, Zhenxing; Huang, Kai; Li, Yongle; Li, Dongsheng; Ji, Xiaojun; Huang, Jing; Wang, Jun; Fang, Danhong; Wang, Jian'an; Tang, Lijiang; Liu, Yingwu; Fu, Guosheng; Du, Juan; Wang, Ling; Liu, Mengqi; Ge, Junbo.
Afiliação
  • Cui Z; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qiu Z; Department of Cardiology, Shanghai Tongren Hospital, Shanghai, China.
  • Cheng W; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Hu W; Department of Cardiology, Central Hospital of Minhang District, Shanghai, China.
  • Ma G; Department of Cardiology, Zhongda Hospital Affiliated to Southeast University, Nanjing, China.
  • Cai X; Department of Cardiology, Jinan Central Hospital, Jinan, China.
  • Jin Y; Department of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhao Y; Department of Cardiology, Dalian Jinzhou First People's Hospital, Dalian, China.
  • He L; Department of Cardiology, Wuhan No. 1 Hospital, Wuhan, China.
  • Li Y; Department of Cardiology, Shanghai East Hospital, Shanghai, China.
  • Bu P; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
  • Chen X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
  • Wang R; Department of Cardiology, Wuxi People's Hospital, Wuxi, China.
  • Chen L; Department of Cardiology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Dong P; Department of Cardiology, Beijing Aviation General Hospital, Beijing, China.
  • Feng L; Department of Cardiology, Shidong Hospital, Yangpu District, Shanghai, China.
  • Han X; Department of Cardiology, Shanxi Cardiovascular Hospital (Shanxi Cardiovascular Diseases Institute), Taiyuan, China.
  • Hong M; Department of Cardiology, The Second Clinical Medical College of Nanjing Medical University, Nanjing, China.
  • Hou Y; Department of Cardiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Liao M; Department of Cardiology, Baoshan Branch, Shanghai General Hospital, Shanghai, China.
  • Wang M; Department of Cardiology, Putuo People's Hospital, Tongji University, Shanghai, China.
  • Wang X; Department of Cardiology, Wuxi Third People's Hospital, Wuxi, China.
  • Xie J; Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Xu Y; Department of Cardiology, Shanghai Tenth People's Hospital, Shanghai, China.
  • Wang Z; Department of Cardiology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Huang K; Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li Y; Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
  • Li D; Department of Cardiology, Wuhan Third Hospital, Wuhan, China.
  • Ji X; Department of Cardiology, Wenzhou Central Hospital, Wenzhou, China.
  • Huang J; Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Wang J; Department of Cardiology, Jing'an District Central Hospital of Shanghai, Shanghai, China.
  • Fang D; Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang J; Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Tang L; Department of Cardiology, Zhejiang Hospital, Hangzhou, China.
  • Liu Y; Department of Cardiology, Tianjin Third Central Hospital, Tianjin, China.
  • Fu G; Department of Cardiology, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Du J; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
  • Wang L; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
  • Liu M; Medical Department, Daiichi Sankyo (China) Holdings Co., Ltd, Shanghai, China.
  • Ge J; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
J Clin Hypertens (Greenwich) ; 26(1): 5-16, 2024 01.
Article em En | MEDLINE | ID: mdl-37667532
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Combinação Besilato de Anlodipino e Olmesartana Medoxomila / Hipertensão Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Hypertens (Greenwich) Assunto da revista: ANGIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Combinação Besilato de Anlodipino e Olmesartana Medoxomila / Hipertensão Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Hypertens (Greenwich) Assunto da revista: ANGIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China